Day 2

know more about us

DAY 2 - Friday, 12 March 2021

Session 5: Mucociliary Disorders and TB

Chair: Ibrahim A. Janahi – Qatar

14:00 – 14:25 | Cystic Fibrosis; The Year In Review
                         Asma Al Nuaimi – UAE

 

14:25 – 14:50 | Primary Ciliary Dyskinesia: Current Update
                         Claire Hogg – UK

 

14:50 – 15:15 | Current Updates on Tuberculosis
                         Amr Albanna – KSA

15:15 – 15:25 BREAK

Session 6: Interstitial Lung Disease

Chair: Nuha Alrajhi – KSA

15:25 – 15:50 | Transbronchial Cryobiopsy in ILDs
                         Felix Herth – Germany

 

15:50 – 16:15 | Progressive Non-IPF ILD: Clinical Implication
                         Rahmah Alsilmi – KSA

 

16:15 – 16:40 | Antifibrotic Therapies in IPF and Non-IPF ILD
                         Steven Nathan – USA

 

16:40 – 17:05 | Updates on Interstitial Lung Disease Management                        Boehringer Ingelheim
                          Sami Al Yami – USA

17:05 – 17:15 BREAK

Session 7: Severe Asthma – I

Chair: Bassam Mahboub – UAE

17:15 – 17:40 | Navigating Through the Complexities of Asthma Molecular Soup
                         Qutayba Hamid – UAE

 

17:40 – 18:05 | Microbiome-Immune Interactions in Adult Asthma
                         James Beck – USA

 

18:05 – 18:30 | Precision Medicine in Severe Asthma; Application of “Omics” Technologies
                         Juan C. Celedón – USA

 

18:30 – 18:55 | Biologic Therapies in Severe Asthma
                         Michael Wechsler – USA

 

18:55 – 19:20 | Treatments for Severe Asthma beyond T2 Inflammation
                          Kian Fan Chung – UK

19:20 – 19:30 BREAK

Session 8: Severe Asthma – II

Chair: Rabea Khouqeer – KSA

19:30 – 19:55 | Markers of Type 2 Asthma and there Role in Severe Asthma                                    Sanofi
                         Ashraf Alzaabi – UAE

 

19:55 – 20:20 | Real World Evidence in Severe Asthma                                                                           GSK
                         Emilio Pizzichini – Brazil

 

20:20 – 20:45 | IgE it, are we close to Precision Medicine?                                                               Novartis
                         Bassam Mahboub – UAE

20:45 – 21:50 | Stand Alone Symposium                             
                         Chair: Riyad Allehebi – KSA


20:50 – 21:15 | The Role of Eosinophilic Immune Dysfunction in Severe EOS Asthma                                   
                         Adeeb Balkhi – KSA

 

21:15 – 21:45 | Biologics: Are they Capable of Leading to Remission?                      
                         Joseph Diaz – USA

 

21:45 – 21:50 | Q&A Panel Discussion & Closing                                                                          
                         Riyad Allehebi – KSA